Image

Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients with Lipedema

Evaluation of Extracorporeal Shockwave Therapy and Complex Decongestive Therapy Results in Patients with Lipedema

Non Recruiting
18 years and older
Female
Phase N/A

Powered by AI

Overview

The aim of the study is to evaluate the results of the Extracorporeal Shockwave Therapy and Complex Decongestive Therapy in patient diagnosed with lipedema.

Description

The collected content will be transferred over SPSS 21.0. The normality distribution of the data will be evaluated with the Shapiro-Wilk Test. Data will be displayed as mean±standard deviation, median (1st quartile-3 quartile), or number(percent). In comparisons between the two consuming variables before and after exercise, if the values fit the normal distribution, the "paires sample t test" is used, if not, the Wilcoxon test is used. In the comparison of 3 groups, one-way ANOVA will be applied if it is normally distributed, and if it does not fit the normal distribution, the Kruskal Wallis test will be applied. Post-hoc analysis was planned for the printer, which was determined to determine the method statistically. To compare categorical protections is to use the Chi-square test. P < 0.05 will be considered future.

Eligibility

Inclusion Criteria:

  • Female
  • 18 years or older
  • Being diagnosed with lipedema according to Wold criteria
  • Having type 1, 2 and 3 lipedema
  • Having stage 1, 2 and 3 lipedema

Exclusion Criteria:

  • Known rheumatic, endocrinological, neuromuscular, dermatological disease, kidney failure, liver failure and malignancy
  • Having undergone surgery for lipedema
  • Having poor circulation, open wound or infection in the lower extremities

Study details
    Lipedema
    Pain

NCT06898125

Giresun University

21 October 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.